EXCYTE (Beijing) Pharmaceutical Technology Development Co., Ltd.
Home
About Us
全部
Introduction
Team
Corporate Honors
History
Pipeline
Technology
News
Job
Contact
中文简体
Home
News
The "patent authorization of bispecific antibody" was approved
2020-02-10 09:53:05
admin
30
Previous
: Special fund support for epidemic prevention scientific research and emergency production in Haidian District in 2020
Next
: The first batch of new technology enterprises to fight against COVID-19 epidemic in Zhongguancun
